Expertise in
5
conditions

Jenny L. Byrne

Hucknall Road, 
Nottingham, ENG, GB 
Expertise in
5
conditions
Hucknall Road, 
Nottingham, ENG, GB 

Overview

Jenny Byrne practices practicing medicine in Nottingham, United Kingdom.

Ms. Byrne is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Leukemia, Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), and Bone Marrow Transplant.

She is actively involved in clinical research, co-authoring 57 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Hucknall Road, Nottingham, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
A Double-Blind, Phase III, Randomised Study to Compare the Efficacy and Safety of Oral Azacitidine (CC-486) Versus Placebo in Subjects With Acute Myeloid Leukaemia or Myelodysplastic Syndromes as Maintenance After Allogeneic Haematopoietic Stem Cell Transplantation
Enrollment Status: Completed
Publish Date: August 14, 2026
Intervention Type: Drug
Study Drug: Azacitidine
Study Phase: Phase 3

57 Total Publications

Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell Transplantation.
Donor HLA-E*01:06 Confers Protection from Relapse and Improved Survival after T cell depleted Matched Unrelated Donor Haematopoietic Cell Transplantation.
Journal: Transplantation and cellular therapy
Published: June 16, 2026

Frequently Asked Questions about Jenny L. Byrne

Is Jenny L. Byrne a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Jenny L. Byrne is classified as an Advanced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jenny L. Byrne participate in research or clinical trials?

Yes. Jenny L. Byrne has published 57 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Jenny L. Byrne's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Byrne's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile